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Background: Global longitudinal strain (GLS) has been shown to be a significant predictor of chemotherapy-induced cardiotoxicity and cardiac 
dysfunction as well as a predictor of all-cause mortality in patients with cardiac disease, but it has not been studied as a predictor of all-cause 
mortality in patients undergoing chemotherapy with normal ejection fractions (EF). Basal longitudinal strain (BLS) is a component of GLS which 
recent studies have suggested may be a more sensitive indicator of global myocardial dysfunction. The aim of this study was to determine the value 
of longitudinal strain by two-dimensional speckle tracking for predicting prognosis in cancer patients undergoing chemotherapy with normal EFs.
Methods: 119 patients with cancer (hematologic - 52, solid tumor - 68) undergoing or scheduled to undergo chemotherapy and with a normal EF 
(> 50%) had assessments of GLS and BLS. GLS was derived by averaging speckle tracking strain in 17 segments of the left ventricle. BLS was derived 
by averaging the 6 basal segments. Comorbidities and Eastern Cooperative Oncology Group Performance Status (ECOGPS) for each patient were 
found by retrospective chart review. Cox regression was used to determine predictors of all-cause mortality.
results: Over an average follow-up of 20.1 ± 12.8 months, 55 patients (46%) died. Univariate predictors of all-cause mortality (p<0.10) were 
ECOGPS (p<0.0001), sex (p=0.001), age (p=0.03), hematologic vs. solid cancer (p=0.04), beta blocker usage (p=0.05), BLS (p<0.0001), and GLS 
(p=0.002). Multivariate analysis of all significant univariate variables showed that ECOGPS (p<0.0001, HR 1.97 [1.46-2.71]), sex (p=0.009, HR 2.04 
[1.20-3.47]), and BLS (p=0.0009, HR 0.866 [0.796-0.943]) were significant independent predictors of mortality. Stepwise analysis of all significant 
multivariate variables showed increase in global ρ2 (p=0.001) from 36.98 to 47.76 after adding BLS stepwise to combined sex and ECOGPS.
conclusions: ECOGPS, sex, and BLS were significant predictors of all-cause mortality in cancer patients with normal EFs receiving chemotherapy. 
BLS provides incremental prognostic information when added to clinical variables.
